Underestimating the real burden of invasive fungal infections in hematopoietic stem cell transplant recipients?

Clinical Infectious Diseases

Volumn 51, Issue 2, 2010, Pages 253-254

  Hoenigl, Martin ^a   Valentin, Thomas ^a   Salzer, Helmut J F ^a   Zollner Schwetz, Ines ^a   Krause, Robert ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; IMMUNOSUPPRESSIVE AGENT;

AUTOPSY; BRONCHOSCOPY; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INFECTION PREVENTION; INVASIVE ASPERGILLOSIS; LETTER; MYCOSIS; PRIORITY JOURNAL; HUMAN; IMMUNOCOMPROMISED PATIENT; MYCOSES;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MYCOSES;

EID: 77954705618     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/653684     Document Type: Letter

References (3)

1. Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the transplant-associated infection surveillance network (TRANSNET) database. Clin Infect Dis 2010; 50(8):1091-1100.
2. Maertens J, Maertens V, Theunissen K, et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 2009; 49(11):1688-1693.
3. Hoenigl M, Zollner-Schwetz I, Sill H, et al. Epidemiology of invasive fungal infections and rational for antifungal therapy in patients with haematological malignancies. Mycoses (in press).